Shambhavi Naik

By

Considerations underlying Prioritisation of COVID-19 vaccine recipients

The scale and rampant spread of COVID-19 has generated a huge challenge for the world. While vaccine candidates are racing through the trial process, countries are gearing up to administer the early vaccines to their populace. It is obvious that initially...

Takshashila Discussion SlideDoc – A Strategy to make India a Biotech Leader by 2025

Download the Discussion SlideDoc in PDF The biotechnology and healthcare sectors will underpin India’s effort to manage the COVID-19 pandemic, revive the economy and maintain long-term economic competitiveness. However, key internal challenges including regulatory opacity, supply chain friction, and shortage...

Takshashila Discussion Document – Analysis of COVID-19 Serosurveys in India

Download the Discussion Document in PDF The Union and various state governments have conducted seroprevalence surveys at national and city/state levels to study the spread of COVID-19. We argue The disparity in estimated cases as per seroprevalence studies and actual detected...

A COVID-19 Vaccine Deployment Strategy for India

This paper first appeared in Indian Public Policy Review 2020, 1(2): 42 – 58 by Shambhavi Naik, Ameya Paleja, Mihir Mahajan, Narayan Ramachandran, Sunila Dixit, Rahul Matthan, Nitin Pai and Pranay Kotasthane Abstract Deploying COVID-19 vaccines once they are available is...

Centre raises hopes of free COVID-19 vaccine, but benevolence can’t be at the cost of the economy

This article first appeared in the Firstpost.  COVID-19 has assaulted the health of people and economies. The impact on the economy has led to further stress on people’s livelihoods. This unprecedented threat to public health has not been constrained by...

All Things Policy: Is Herd Immunity a Viable Strategy for COVID-19?

A recent declaration from a group of experts calls for a different strategy to deal with COVID-19: one of achieving herd immunity while protecting the vulnerable. The majority of experts oppose this, pointing out that the idea is impractical and...

Serosurveys point to inadequacies in India’s COVID-19 testing strategy

Over the past few months, a series of serosurveys for detecting the spread of COVID-19 have been carried out in India. The surveys are meant to identify the percentage of the Indian population with antibodies against SARS-CoV-2, as an indicator of how widespread...

All Things Policy: Ethics in Clinical Trials

ICMR’s 2017 ethical guidelines need a revision, with more focus on fundamental principles that govern the moral decisions and on ethical dilemmas that arise while conducting clinical trials/biomedical and health research. Sowmya Nandan talks to Sunila Dixit and Shambhavi Naik...

All Things Policy: Celebrities and Vaccines, From the 19th Century to the Present

Can celebrities help build trust in a new vaccine? Shambhavi Naik and Anirudh Kanisetti talk to Aditya Ramanathan about the historical role celebrities have played in facilitating vaccinations in India since the early 1800s and why authorities could use platforms...

WHO’s COVAX Vaccine Access Initiative Won’t Succeed Without India’s Help

by Ruturaj Gowaikar and Shambhavi Naik Despite multiple lockdowns, forms of treatment and therapies, and intermittently aggressive contact-tracing, countries around the world have failed to arrest the spread of the novel coronavirus to the extent they had intended. A vaccine...
1 2 3 4 18